Biotech entity
gene-therapy is the sole category represented across all 1 tracked stories. Patrick Magri is most often covered alongside Hereditary Angioedema (HAE), which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Patrick Magri appears in 1 tracked Biotech story from February 26, 2026.
Last mentioned: Feb 26, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
gene-therapy is the sole category represented across all 1 tracked stories. Patrick Magri is most often covered alongside Hereditary Angioedema (HAE), which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Patrick Magri appears in 1 tracked Biotech story from February 26, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Patrick Magri. Shared-story counts are live from our verified record — not editorial picks.
Functional Cure Declared
Medical reports confirm the patient is effectively cured of the rare disease.
Long-term Follow-up
B.C. patient reports zero attacks one year after single dose.
Phase 1/2 Results
Intellia releases early data showing significant reduction in HAE attacks.
A British Columbia man has been declared functionally cured of Hereditary Angioedema (HAE) following a world-first in-vivo CRISPR gene-editing treatment. The success of Intellia Therapeutics' NTLA-2002 therapy marks a pivotal shift from chronic disease management to permanent genetic correction.
Patrick Magri is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
